Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria and Active Hemolysis
NCT06050226Phase 2Completed
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Jul 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MY-008 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Wuhan Createrna Science and Technology Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
MY-008
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06050226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06050226.